BillionaireNet
Nadler
Daniel Nadler
Rank #994
CANADATechnologyAI software

Daniel Nadler

Net Worth
$4.055B
0% (24h)
Daniel Nadler is a Canadian-born tech entrepreneur, poet, and artist, currently ranked #991 in the world. As the founder of OpenEvidence, an AI-powered medical search engine, he has revolutionized how physicians access medical information. His company, often called "ChatGPT for doctors," has gained rapid adoption, with 40% of U.S. doctors using the platform. Nadler's success story includes founding Kensho Technologies, an AI company acquired by S&P Global, and a debut poetry collection, showcasing his diverse background.

The Full Dossier

Early Life

Daniel Nadler was born in Toronto, Ontario, Canada, to parents who were immigrants from Poland and Romania. He pursued a diverse education at Harvard University, earning a Ph.D. with a thesis on the pricing of credit derivatives while also studying poetry under Pulitzer Prize-winning poet Jorie Graham.

Rise to Success

In 2013, Nadler co-founded Kensho Technologies, an AI company that developed machine-learning systems for financial analysis, later acquired by S&P Global for $550 million in 2018. In 2021, Nadler founded OpenEvidence, an AI company whose medical search engine is used by doctors for clinical decision support. OpenEvidence has rapidly grown, with over 430,000 physicians using it, and is adding new users at a rate of 65,000 per month. OpenEvidence secured $210 million in Series B funding, which propelled its valuation to $3.5 billion.

Key Business Strategies

OpenEvidence's strategy focuses on providing a free, high-quality tool directly to clinicians. The company earns revenue through an advertising model, partnering with pharmaceutical companies. OpenEvidence has also partnered with the New England Journal of Medicine, which grants it permission to use all of the journal's findings from 1990 onwards.

Philanthropy

While specific details of his philanthropy are not available, Nadler's commitment to the arts is evident through his role on the board of directors of the Academy of American Poets.

Career Timeline

2025

TIME100 Health List

Featured on the TIME100 Health list of the 100 most influential individuals in global health.

2021

Founded OpenEvidence

An AI-powered medical search engine.

2018

Sold Kensho Technologies

Sold to S&P Global for $550 million.

2016

Published poetry collection

"Lacunae: 100 Imagined Ancient Love Poems"

2013

Co-founded Kensho Technologies

An AI company later acquired by S&P Global.

Wealth Trajectory